Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04764552
Other study ID # PRO-FY2021-94
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 9, 2021
Est. completion date June 7, 2021

Study information

Verified date December 2021
Source University of Memphis
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will compare the impact of the Yeahhh Baby! Ointment, as compared to a placebo, on measures of joint pain and discomfort in those who regularly experience joint pain. The hypothesis is that perceived pain will be reduced when subjects use the Yeahhh Baby! Ointment. Previous studies exploring the efficacy of topicals on joint pain relief have used a similar design and similar joint pain assessments as employed herein (The Western Ontario and McMaster Universities Arthritis Index [WOMAC] and visual analog scale [VAS] for pain).


Description:

Joint pain is a common ailment among adults in the United States. In 2014, an estimated 14.6 million Americans with arthritis suffered from severe joint pain. It is therefore unsurprising that many topical ointments are currently marketed for joint pain relief including Bengay®, Icy Hot®, Jointflex®, and Aspercreme®. These ointments aim to reduce pain often through a combination of analgesic ingredients include capsaicin, salicylates, menthol, camphor, and lidocaine. Bengay® products, for instance, contain one or more of menthol, camphor, salicylates, and lidocaine. Icy Hot® products contain menthol, while some also include lidocaine. Yeahhh Baby! ointment is an herbal (botanical: plant-based) treatment for those impacted by joint pain. The product contains a variety of herbal ingredients that have been touted by some within the alternative medicine community as "healing agents." The product started selling in 2016 and is available commercially as an all-natural alternative to other commercially available products. This ointment consists primarily of coconut oil (98%), with magnesium and small amounts of herbal ingredients (tanner's bark, slippery root, sweet weed, velvet plant, walnut hulls, kidney root, green ginger, Indian pink, mad dogweed, and nigella seed) thought to reduce inflammation and to promote tissue healing. The present study will compare the impact of the Yeahhh Baby! Ointment, as compared to a placebo, on measures of joint pain and discomfort in those who regularly experience joint pain. The hypothesis is that perceived pain will be reduced when subjects use the Yeahhh Baby! Ointment. Previous studies exploring the efficacy of topicals on joint pain relief have used a similar design and similar joint pain assessments as employed herein (The Western Ontario and McMaster Universities Arthritis Index [WOMAC] and visual analog scale [VAS] for pain).


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date June 7, 2021
Est. primary completion date June 7, 2021
Accepts healthy volunteers No
Gender All
Age group 35 Years to 65 Years
Eligibility Inclusion Criteria: - Self-reported joint pain with a minimum pain rating of 3/10 for at least the past 30 days - Recreationally active (2 or more days per week) - Not obese (BMI < 30kg/m2) Exclusion Criteria: - Tobacco users/Smokers - Allergic to coconut, walnuts, oak, olives - Currently using anti-inflammatory medicines or dietary supplements (and not willing to cease for one-month prior to participation and throughout study)

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Yeahhh Baby Ointment
The ointment consists primarily of coconut oil (98%), with small amounts of herbal ingredients (tanner's bark, slippery root, sweet weed, velvet plant, walnut hulls, kidney root, green ginger, Indian pink, mad dogweed, and nigella seed) thought to reduce inflammation and to promote tissue healing.
Other:
Coconut oil ointment
Coconut oil ointment with a little olive oil.

Locations

Country Name City State
United States Center for Nutraceutical and Dietary Supplement Reseach Memphis Tennessee

Sponsors (2)

Lead Sponsor Collaborator
University of Memphis YEAHHH! BABY LLC

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Joint pain visual analog scale A 100mm visual analog scale will be used to assess join pain. Scores range from 0 (subject strongly disagreeing with prompt) to 100 (strongly agree) days 1-14
Primary Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) The WOMAC measures five items for pain (score range 0-20), two for stiffness (score range 0-8), and 17 for functional limitation (score range 0-68) with 0 being none and high values being most. days 1-14
Primary Blood pressure Resting blood pressure will be measured. First 1 day
Primary Blood pressure Resting blood pressure will be measured. 15th day
Primary Heart Rate Resting heart rate will be measured. First 1 day
Primary Heart Rate Resting heart rate will be measured. 15th day
See also
  Status Clinical Trial Phase
Completed NCT05052112 - Cross-Over Study to Evaluate the Efficacy of E-PR-01 on Activity Induced Joint Pain N/A
Recruiting NCT04285112 - SPRINT: Signature for Pain Recovery IN Teens
Completed NCT04506411 - Turmeric Efficacy for Mobility and Joint Function N/A
Terminated NCT00973141 - A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain Phase 2
Completed NCT04408560 - Evaluation of the Efficacy of a Homeopathic Protocol in Patients With Non-metastatic Breast Cancer N/A
Completed NCT04150211 - Effects of Exten(d) Supplementation on Training Ability in Recreational Runners Phase 2
Completed NCT03209895 - Study to Evaluate the Safety and Efficacy of a Proprietary "Joint Health" Dietary Supplement in Subjects With Joint and Connective Tissue Pain N/A
Withdrawn NCT01612728 - Treatment for Joint Pains Due to Aromatase Inhibitor Therapy in Breast Cancer Phase 2
Completed NCT00691678 - Glucosamine and Chondroitin for Aromatase Inhibitor Induced Joint Symptoms in Women With Breast Cancer Phase 2
Recruiting NCT05212259 - Clinical Study to Evaluate the Effect of Different Doses of UC-II® Supplementation on the Range of Motion & Joint Discomfort in Healthy Subjects N/A
Recruiting NCT04182659 - Long Term Efficacy of Neuronavigation Guided rTMS in Alleviating Gulf War Illness Related Headaches and Pain Symptoms N/A
Terminated NCT04712019 - Evaluating Edema and Range of Motion Using Negative Pressure Therapy vs. Standard Surgical Dressing in Bilateral TKA N/A
Recruiting NCT06074744 - Subsartorial Nerve Block and Femoral Nerve Block in Total Knee Arthroplasty N/A
Recruiting NCT00325845 - Synvisc Injections for Lumbar Facet Joint Pain Phase 3
Terminated NCT04872556 - Evaluation of the Effect of Laser Acupuncture on Taxane Acute Pain Syndrome Patients N/A
Active, not recruiting NCT03865992 - Curcumin in Reducing Joint Pain in Breast Cancer Survivors With Aromatase Inhibitor-Induced Joint Disease N/A
Recruiting NCT05282992 - NAtive Collagen Type II In Healthy VoluntEers With Joint Discomfort N/A
Recruiting NCT04994249 - Diagnostic and Prognostic Biomarkers for High-impact Chronic Pain: Development and Validation
Completed NCT01509079 - Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors Phase 2
Completed NCT04764110 - Short-term Impact of Cyplexinol® on Self-reported Joint Pain N/A